Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

The U.S. Food and Drug Administration today issued a guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic.
Dr. Anghel Adrian Udrea describes cancer care barriers in Romania and why he chose to start his own cancer center. Read more. 
The American Medical Association’s (AMA) CPT Editorial Panel created a new CPT code effective March 13, 2020 to describe coronavirus testing provided by hospitals, health systems and laboratories in the United States. CPT® Code Description 87635-Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique
ASCO has compiled COVID-19 Clinical Oncology Frequently Asked Questions (FAQs) to answer questions from members who are treating individuals with cancer during the coronavirus pandemic. ASCO strives to provide the best available information, recognizing that the evidence base to support best practices, under these circumstances, is limited and evolving.
In a letter to the Centers for Medicare & Medicaid Services (CMS), the Association for Clinical Oncology (ASCO) expressed concerns regarding two provisions in the 2021 Affordable Care Act (ACA) Notice of Benefit and Payment Parameters proposed rule. This proposal, if implemented, would update the regulatory and financial standards applied to ACA Exchanges.
In a letter to Representatives Terri Sewell (D-AL), Adrian Smith (R-NE), Tony Cárdenas (D-CA), and John Shimkus (R-IL), the Association for Clinical Oncology (ASCO) conveyed its support for legislation the lawmakers introduced in the U.S. House of Representatives. The bill, H.R.
Statement By American Society of Clinical Oncology (ASCO) President Howard A. “Skip” Burris III, MD, FACP, FASCO “We commend the U.S. Food and Drug Administration (FDA) for releasing draft guidance to encourage inclusion of older adults in clinical trials of drugs for the treatment of cancer. We thank Richard Pazdur, MD, director of the FDA Oncology Center of Excellence, for his leadership on this important issue.
The Centers for Medicare & Medicaid Services (CMS) issued frequently asked questions and answers (FAQs) for healthcare providers regarding Medicare payment for laboratory tests and other services related to the 2019-Novel Coronavirus (COVID-19). The agency is receiving questions from providers and created this document to be transparent and share answers to some of the most common questions. Included in the FAQs: